Mounjaro KwikPen Tirzepatide 12.5mg/0.6ml, Four-Dose Pre-Filled Injection 1 Pen For Subcutaneous Injection

Brand Logo
Lilly
Visit store
Get it in 3 hours
Share
Product
Description

Mounjaro (Tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist indicated for type 2 diabetes management and clinical weight reduction. The 12.5mg concentration provides advanced physiological support by augmenting insulin secretion and delaying gastric emptying to maintain glycemic stability.

Dosage & Administration

  • Dosage: Adhere strictly to the dosing schedule and administration instructions provided by your physician.
  • Method: Subcutaneous injection into the abdomen, thigh, or upper arm.
  • Site Rotation: Rotate injection sites with each weekly dose to minimize tissue irritation.
  • Cycle: One KwikPen contains 4 fixed doses (one month supply)
  • Missed Dose Protocol: Administer a missed dose within 4 days of the scheduled date. If more than 4 days have elapsed, the missed dose should be omitted. It should be resumed on their usual schedule day. The interval between two consecutive doses must not be less than 72 hours.

Technical Specification

  • Form: Multi-dose pre-filled delivery device (KwikPen).
  • Active Ingredient: Tirzepatide.
  • Concentration: 12.5 mg Tirzepatide

Ingredient Functionality

  • Dual Agonism: Tirzepatide selectively binds to and activates both GIP and GLP-1 receptors. This dual action enhances metabolic efficiency more than single-receptor agonists.
  • Glucagon Regulation: Suppresses glucagon secretion from pancreatic alpha cells in a glucose-dependent manner, lowering hepatic glucose output.
  • Gastric Kinetics: Prolongs gastric emptying time, which flattens postprandial glucose peaks and promotes prolonged satiety.

Safety & Storage

  • Temperature Control: Store in a refrigerator between 2°C and 8°C. Protect from light.
  • Ambient Storage: The pen may be kept at room temperature (up to 25°C) for a maximum of 21 days; discard if not used within this window.
  • Device Disposal: The pen must be discarded 28 days after the first dose is administered.
  • Warning: Do not use if the solution is cloudy, discolored, or contains visible particles.
  • Compatible needles are required for administration; not included in this package.